Company Analysis
Sign in

Niki BioSolutions, Inc. (NIKI)

Nasdaq: NIKI · Measuring & Controlling Devices, NEC · London, GB · filing with the SEC since 2018
Full chart Alerts Compare
Grade3.6
◀ Past 3.4● Present 2.6▶ Future 5.0
4 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2023, as filed
Revenue$431,378-66.7%
Net income-$2.8M+71.2%
Earnings per share$-0.62+77.5%
Operating cash flow-$7.7M+37.3%
Cash$2.0M-60.0%
Debtn/a
Shareholders’ equity$15.4M+96.4%
Shares, diluted4,521,133+26.7%
Return on equity-9.9%
The recordfrom its filings
Filings in 202643
Newest filingNov 12 · 3
Annual reportMar 27, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents grantedn/a
Filer categoryNon-accelerated filer<br>Smaller reporting company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
1819202122232425
As filed, in USD. Nothing here is a forecast.

News

Oct 21, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 21, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 21, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 13, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Oct 9, 2026 · SEC EDGAR · Form EFFECT
Registration effective
Open the filing on sec.gov
Oct 9, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Oct 9, 2026 · SEC EDGAR · Form 424B5
Shelf offering
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton NIKI · research, not advice